COMMUNIQUÉS West-GlobeNewswire

Prospective, Multi-center Study Published in Future Oncology Demonstrates DecisionDx®-Melanoma’s i31-SLNB Result Outperforms Staging Criteria in Identifying Patients with Cutaneous Melanoma Below the 5% NCCN Threshold for Forgoing SLNB
13/03/2026
Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those predicted to have less than 5% risk of a positive sentinel lymph node (SLN) by DecisionDx- [...]
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13/03/2026
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring importance of early diagnosis and [...]
Disclosure of a transparency notification from Mawer Investment Management Ltd
13/03/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 March 2026 – 6 PM CET Disclosure of a transparency notification from Mawer Investment Management Ltd Pursuant to the Belgian act of 2 May 2007 on [...]
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
13/03/2026
Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the [...]
Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
13/03/2026
SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Connected Innovation and Specialty-Specific AI Take Center Stage at Nextech EDGE 2026
13/03/2026
TAMPA, Fla., March 13, 2026 (GLOBE NEWSWIRE) -- Specialty leaders from across the country are gathering at Nextech EDGE 2026 , the company’s annual user conference designed to bring together customers, partners, and [...]
SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
13/03/2026
IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise [...]
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
13/03/2026
Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression 14-Month Follow-up Data Show Hypoimmune (HIP)-Modified Islets are [...]
Equillium Announces $35 Million Financing with RA Capital Management
13/03/2026
Capital strengthens the advancement of EQ504 through key clinical milestones Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2029 LA JOLLA, Calif., March 13, [...]
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
13/03/2026
New data supports GraftAssure commercialization efforts Multi-center study featured 249 biopsy-matched patients Proprietary “Combination Model” score outperformed percentage-only measures of dd-cfDNA Reinforces data [...]
New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row
13/03/2026
Ranked Top 50 in the Nation for 2026 New York, NY, March 13, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group) and Deep Blue Med Spa (DBMS) are proud to announce that they have once again been [...]
Blue Cross and Blue Shield of Minnesota Advances Collaborative Efforts to Improve Outcomes and Close Gaps in Care
13/03/2026
Excellence in Quality and Outcomes (EQO) Program establishes a shared-data, partnership-driven approach to improving health outcomes EAGAN, Minn., March 13, 2026 (GLOBE NEWSWIRE) -- Blue Cross and Blue Shield of [...]
Sienna Announces March Dividend
13/03/2026
MARKHAM, Ontario, March 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
13/03/2026
GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it granted equity awards on March 10, [...]
23andMe Introduces Reconstructed Ancestors a First-of-Its-Kind DNA Discovery Tool
13/03/2026
Reconstructed Ancestors sets a new industry standard to help reveal deeper family connections and fill gaps in a family tree with greater precision. PALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- 23andMe , a [...]
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
13/03/2026
Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and expansion of Akari’s ADC pipeline Access the Akari CEO Corner here TAMPA, Fla. and LONDON, March 13, [...]
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
13/03/2026
National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50 Many respondents report undergoing five or more cystoscopies, with some [...]
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis
13/03/2026
Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility Analysis SYDNEY, AUSTRALIA, March 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” [...]
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
13/03/2026
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and autoimmune pipeline assets and to build on the Company’s base of high caliber [...]

Pages